This 3-arm randomized pragmatic clinical trial will test the efficacy of patient-focused continuous glucose monitoring (Arm 1 – “patient-only CGM”) and patient/provider-focused continuous glucose monitoring (Arm 2 – “patient + provider CGM”) intervention strategies, compared to an active comparator (Arm 3 “usual care”) within Kaiser Permanente Northern California. Our 3-arm design allows us to examine whether patient-education and training alone is sufficient to realize a benefit from continuous glucose monitoring without implementing major workflow changes in busy primary care practices. If successful, this study will improve safety, including reduced incidence of severe hypoglycemia and patient-centered outcomes, and improve care processes for older patients with type 2 diabetes.
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes
Investigator: Grant, Richard
Funder: National Institute of Diabetes and Digestive and Kidney Diseases